David Maussang

2.7k total citations
23 papers, 2.0k citations indexed

About

David Maussang is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, David Maussang has authored 23 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in David Maussang's work include Chemokine receptors and signaling (8 papers), Cytomegalovirus and herpesvirus research (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). David Maussang is often cited by papers focused on Chemokine receptors and signaling (8 papers), Cytomegalovirus and herpesvirus research (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). David Maussang collaborates with scholars based in Netherlands, United States and Belgium. David Maussang's co-authors include Martine J. Smit, Rob Leurs, Guus A.M.S. van Dongen, Sérgio A. Lira, Pieter J. Gaillard, Erik Slinger, Detlef Michel, Andreas Schreiber, Chantal C.M. Appeldoorn and Danny J. Scholten and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

David Maussang

23 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Maussang Netherlands	20	794	691	670	553	430	23	2.0k
Alain C. Tissot Switzerland	14	617 0.8×	344 0.5×	1.0k 1.5×	295 0.5×	328 0.8×	23	2.2k
Junho Chung South Korea	24	939 1.2×	406 0.6×	310 0.5×	237 0.4×	436 1.0×	99	1.8k
Oliver M.T. Pearce United Kingdom	23	1.3k 1.6×	623 0.9×	923 1.4×	113 0.2×	186 0.4×	43	2.5k
Samit Chatterjee United States	22	860 1.1×	979 1.4×	670 1.0×	175 0.3×	494 1.1×	35	2.4k
Efstratios Stratikos Greece	34	1.2k 1.5×	1.1k 1.6×	1.1k 1.6×	667 1.2×	149 0.3×	99	3.2k
Abner M. Mhashilkar United States	32	1.3k 1.6×	1.4k 2.1×	989 1.5×	144 0.3×	218 0.5×	47	3.0k
Zoë Johnson Switzerland	19	1000 1.3×	1.2k 1.7×	1.2k 1.7×	127 0.2×	187 0.4×	43	2.6k
Anders Elm Pedersen Denmark	31	914 1.2×	618 0.9×	1.4k 2.1×	200 0.4×	214 0.5×	87	2.4k
Luis Álvarez‐Vallina Spain	29	1.5k 1.9×	1.2k 1.8×	785 1.2×	81 0.1×	943 2.2×	93	2.9k
Doreen M. Floß Germany	25	711 0.9×	514 0.7×	792 1.2×	133 0.2×	187 0.4×	61	1.8k

Countries citing papers authored by David Maussang

Since Specialization

Citations

This map shows the geographic impact of David Maussang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Maussang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Maussang more than expected).

Fields of papers citing papers by David Maussang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Maussang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Maussang. The network helps show where David Maussang may publish in the future.

Co-authorship network of co-authors of David Maussang

This figure shows the co-authorship network connecting the top 25 collaborators of David Maussang. A scholar is included among the top collaborators of David Maussang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Maussang. David Maussang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Geuijen, Cecile, David Maussang, Tristan Gallenne, et al.. (2021). Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade. Cancer Cell. 39(8). 1163–1164. 2 indexed citations

Senten, Jeffrey R. van, Maarten P. Bebelman, Raimond Heukers, et al.. (2019). The human cytomegalovirus-encoded G protein–coupled receptor UL33 exhibits oncomodulatory properties. Journal of Biological Chemistry. 294(44). 16297–16308. 23 indexed citations

Schram, Alison M., Eileen M. O’Reilly, Romel Somwar, et al.. (2019). Abstract PR02: Clinical proof of concept for MCLA-128, a bispecific HER2/3 antibody therapy, in NRG1 fusion-positive cancers. Molecular Cancer Therapeutics. 18(12_Supplement). PR02–PR02. 24 indexed citations

Geuijen, Cecile, David Maussang, Tristan Gallenne, et al.. (2018). Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade. Cancer Cell. 33(5). 922–936.e10. 84 indexed citations

Doornbos, Robert P., Alexander B. H. Bakker, Kees Bol, et al.. (2018). Translational PK-PD modeling analysis of MCLA-128, a HER2/HER3 bispecific monoclonal antibody, to predict clinical efficacious exposure and dose. Investigational New Drugs. 36(6). 1006–1015. 31 indexed citations

Heukers, Raimond, et al.. (2017). CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome. Journal of Pharmacology and Experimental Therapeutics. 363(1). 35–44. 25 indexed citations

Maussang, David, Jaap Rip, Angelique van den Heuvel, et al.. (2016). Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo. Drug Discovery Today Technologies. 20. 59–69. 65 indexed citations

Rip, Jaap, Linda Chen, Robin Hartman, et al.. (2014). Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood–brain barrier in rats. Journal of drug targeting. 22(5). 460–467. 119 indexed citations

Gaillard, Pieter J., Chantal C.M. Appeldoorn, Rick Dorland, et al.. (2014). Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101). PLoS ONE. 9(1). e82331–e82331. 208 indexed citations

10.

Maussang, David, Francis J. Descamps, Catelijne Stortelers, et al.. (2013). Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo. Journal of Biological Chemistry. 288(41). 29562–29572. 124 indexed citations

11.

Wijtmans, Maikel, David Maussang, Francesco Sirci, et al.. (2012). Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists. European Journal of Medicinal Chemistry. 51. 184–192. 51 indexed citations

12.

Voermans, Carlijn, Karel A. van Dort, Neeltje A. Kootstra, et al.. (2012). Regulation of CXCR4 conformation by the small GTPase Rac1: implications for HIV infection. Blood. 119(9). 2024–2032. 19 indexed citations

13.

Klarenbeek, A., David Maussang, Christophe Blanchetot, et al.. (2012). Targeting chemokines and chemokine receptors with antibodies. Drug Discovery Today Technologies. 9(4). e237–e244. 35 indexed citations

14.

Scholten, Danny J., Meritxell Canals, David Maussang, et al.. (2011). Pharmacological modulation of chemokine receptor function. British Journal of Pharmacology. 165(6). 1617–1643. 200 indexed citations

15.

Bongers, Gerold, David Maussang, Luciana R. Muniz, et al.. (2010). The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice. Journal of Clinical Investigation. 120(11). 3969–3978. 89 indexed citations

16.

Maussang, David, Ellen Langemeijer, Carlos P. Fitzsimons, et al.. (2009). The Human Cytomegalovirus–Encoded Chemokine Receptor US28 Promotes Angiogenesis and Tumor Formation via Cyclooxygenase-2. Cancer Research. 69(7). 2861–2869. 128 indexed citations

17.

Maussang, David, Henry F. Vischer, Andreas Schreiber, Detlef Michel, & Martine J. Smit. (2009). Chapter 7 Pharmacological and Biochemical Characterization of Human Cytomegalovirus‐Encoded G Protein–Coupled Receptors. Methods in enzymology on CD-ROM/Methods in enzymology. 460. 151–171. 7 indexed citations

18.

Maussang, David, Henry F. Vischer, Rob Leurs, & Martine J. Smit. (2009). Herpesvirus-Encoded G Protein-Coupled Receptors as Modulators of Cellular Function. Molecular Pharmacology. 76(4). 692–701. 13 indexed citations

19.

Shang, Limin, Masayuki Fukata, Nanthakumar Thirunarayanan, et al.. (2008). Toll-Like Receptor Signaling in Small Intestinal Epithelium Promotes B-Cell Recruitment and IgA Production in Lamina Propria. Gastroenterology. 135(2). 529–538.e1. 154 indexed citations

20.

Maussang, David, Dennis Verzijl, Marijke van Walsum, et al.. (2006). Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proceedings of the National Academy of Sciences. 103(35). 13068–13073. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact